Harmony Biosciences Holdings, Inc. (HRMY)
37.26
+1.26
(+3.50%)
USD |
NASDAQ |
Jul 02, 16:00
36.00
-1.26
(-3.38%)
After-Hours: 20:00
Harmony Biosciences Holdings Price to Book Value : 2.368 for July 2, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| July 02, 2026 | 2.368 |
| July 01, 2026 | 2.288 |
| June 30, 2026 | 2.314 |
| June 29, 2026 | 2.246 |
| June 26, 2026 | 2.255 |
| June 25, 2026 | 2.170 |
| June 24, 2026 | 2.190 |
| June 23, 2026 | 2.171 |
| June 22, 2026 | 2.125 |
| June 18, 2026 | 2.116 |
| June 17, 2026 | 2.147 |
| June 16, 2026 | 2.150 |
| June 15, 2026 | 2.173 |
| June 12, 2026 | 2.190 |
| June 11, 2026 | 2.238 |
| June 10, 2026 | 2.255 |
| June 09, 2026 | 2.168 |
| June 08, 2026 | 2.059 |
| June 05, 2026 | 2.047 |
| June 04, 2026 | 2.095 |
| June 03, 2026 | 2.040 |
| June 02, 2026 | 1.965 |
| June 01, 2026 | 2.022 |
| May 29, 2026 | 2.008 |
| May 28, 2026 | 2.002 |
| Date | Value |
|---|---|
| May 27, 2026 | 1.955 |
| May 26, 2026 | 1.913 |
| May 22, 2026 | 1.916 |
| May 21, 2026 | 1.938 |
| May 20, 2026 | 1.995 |
| May 19, 2026 | 1.935 |
| May 18, 2026 | 1.896 |
| May 15, 2026 | 1.913 |
| May 14, 2026 | 1.955 |
| May 13, 2026 | 1.960 |
| May 12, 2026 | 1.916 |
| May 11, 2026 | 1.918 |
| May 08, 2026 | 1.970 |
| May 07, 2026 | 1.997 |
| May 06, 2026 | 2.084 |
| May 05, 2026 | 2.056 |
| May 04, 2026 | 2.072 |
| May 01, 2026 | 2.023 |
| April 30, 2026 | 1.987 |
| April 29, 2026 | 1.974 |
| April 28, 2026 | 1.981 |
| April 27, 2026 | 1.974 |
| April 24, 2026 | 1.958 |
| April 23, 2026 | 2.039 |
| April 22, 2026 | 2.032 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 3.502 |
| Johnson & Johnson | 7.797 |
| Indivior Pharmaceuticals, Inc. | -- |
| Royalty Pharma Plc | 3.720 |
| Corcept Therapeutics, Inc. | 15.18 |
Price to Book Value Related Metrics
| PE Ratio | 15.01 |
| PS Ratio | 2.431 |
| Price to Free Cash Flow | 6.776 |
| Price | 37.26 |
| Earnings Yield | 6.66% |
| Market Cap | 2.156B |
| Operating PE Ratio | 11.53 |
| Normalized PE Ratio | 15.01 |